Canopy Growth Corp (WEED.TO) continues to face challenges in the market this week, with its stock reflecting a downward trend amid broader industry developments.
This week, Canopy Growth Corp's stock price has seen a decline, closing at C$1.30, down 0.78% for the day and 3.03% over the past week. The company has been active in expanding its product offerings and maintaining shareholder engagement, but market sentiment remains cautious as reflected in its performance.
Investor takeaway: Investors should consider the recent developments and the company's strategic efforts to expand its market presence, while also being mindful of the stock's volatility and the broader market conditions.
Advertisement
Canopy Growth Corp
WEED.TO
WEED.TO
Canopy Growth Corp
WealthAwesomeMarket cap
$575.10M
52W high
$3.28
52W low
$1.18
1W change
-3.03%
Beta
2.43
Analyst Price Targets
Based on analyst covering WEED ยท as of Sep 17, 2026
Wall Street analysts forecast WEED stock price to rise 57.8% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$2.02
+57.8% Upside
Current Price
C$1.28
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on WEED's historical volatility
30-Day Vol
34.4%
Annualized
90-Day Vol
39.2%
Annualized
Trend (90d)
-15.9%
Annualized drift
90d Mean
C$1.23
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$1.28 | C$1.13 โ C$1.44 |
| 60 trading days | C$1.25 | C$1.06 โ C$1.48 |
| 90 trading days | C$1.23 | C$1.00 โ C$1.51 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Canopy Growth's Market Cap Stands at C$575 Million
With a profit margin of -79.2% and an EPS of -0.67, Canopy Growth faces significant financial challenges despite its market cap.
Bull case
Canopy Growth's recent efforts to expand its medical cannabis portfolio in Australia and secure EU GMP certification could strengthen its market position and promote future growth.
Bear case
The stock's ongoing price decline, significant losses, and high beta indicate increased volatility and risks for investors in the current market environment.
Recent Price Action
Advertisement
Canopy Growth Corp's stock has experienced a challenging week, closing at C$1.30, marking a decline of 0.78% for the day and 3.03% over the past week. Year-to-date, the stock has fallen by 21.95%. This downward trend reflects ongoing concerns in the cannabis sector, despite the company's efforts to engage shareholders and expand its product offerings.
Company Developments
This week, Canopy Growth has been active in communicating with its shareholders, reminding them to vote ahead of the September 23 deadline for its annual general meeting. Additionally, the company has broadened its medical cannabis portfolio in Australia with new formats and formulations, aiming to capture a larger share of the growing market. Furthermore, Canopy Growth secured renewed EU GMP certification for its Kincardine facility, which is crucial for its European operations.
Technical Picture
From a technical standpoint, Canopy Growth's stock is currently trading below both its 50-day moving average of C$1.35 and its 200-day moving average of C$1.50, indicating bearish momentum. The stock has a 52-week range of C$1.18 to C$3.28, with its current price sitting at approximately 6% of that range. The high beta of 2.43 suggests that the stock is more volatile than the market, which may pose risks for investors. The latest trading volume of 509,099 shares is below the 20-day average volume of 641,564 shares, indicating reduced trading activity.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile โโ Reviewed by Certified Financial Professionals
This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
โ ๏ธ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
